Search This Blog

Wednesday, April 29, 2020

Opko Health launches COVID-19 antibody testing with focus on New York

OPKO Health (OPK +3.9%) unit BioReference Laboratories announces the nation-wide availability of blood tests to detect antibodies to the COVID-19 coronavirus.
Under an agreement with the State of New York, testing will begin there on Metropolitan Transportation Authority (MTA) employees.
The lab says it will be able to process 400K tests per day by mid-May, cautioning that results should be interpreted with other factors such as symptoms and history since protective immunity has been yet been established in clinical trials.
https://seekingalpha.com/news/3566223-opko-health-launches-covidminus-19-antibody-testing-focus-on-new-york

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.